电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

FPR3 抗体 (PE)

This anti-FPR3 antibody is a 小鼠 单克隆 antibody detecting FPR3 in FACS. Suitable for 人.
产品编号 ABIN2662720
发货至: 中国

Quick Overview for FPR3 抗体 (PE) (ABIN2662720)

抗原

See all FPR3 抗体
FPR3 (Formyl Peptide Receptor 3 (FPR3))

适用

  • 39
  • 2
  • 1
  • 1

宿主

  • 36
  • 2
  • 1
小鼠

克隆类型

  • 37
  • 2
单克隆

标记

  • 19
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This FPR3 antibody is conjugated to PE

应用范围

  • 22
  • 19
  • 12
  • 10
  • 10
  • 3
  • 2
  • 1
  • 1
Flow Cytometry (FACS)

克隆位点

K102B9
  • 纯化方法

    The antibody was purified by affinity chromatography and conjugated with PE under optimal conditions. The solution is free of unconjugated PE and unconjugated antibody.

    亚型

    IgG2a kappa
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 缓冲液

    Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .

    储存液

    Sodium azide

    注意事项

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    注意事项

    Protect from prolonged exposure to light. Do not freeze.

    储存条件

    4 °C

    储存方法

    The antibody solution should be stored undiluted between 2°C and 8°C.
  • 抗原

    FPR3 (Formyl Peptide Receptor 3 (FPR3))

    别名

    FPR3

    背景

    FPR3, also known as FPRL2, belongs to the formyl peptide receptor family which includes FPR1, FPR2, and FPR3. Monocytes express FPR1, 2, and 3, upon differentiation into macrophages, expression of these receptors is maintained. Two ligands, humanin and F2L have been identified. Humanin is expressed in the heart, skeletal muscle, kidney, and liver but is not expressed in the immune system. F2L is a heme-binding protein first identified in the spleen. Binding of FPRL2 and F2L induces Ca2+ mobilization and neutrophil chemotaxis. Low level of expression of FPRL2 has also been reported on NK cells.
You are here:
Chat with us!